Literature DB >> 23329140

The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis.

Yaw Asare1, Martin Schmitt, Jürgen Bernhagen.   

Abstract

Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine with chemokine-like functions. MIF is a critical mediator of the host immune and inflammatory response. Dysregulated MIF expression has been demonstrated to contribute to various acute and chronic inflammatory conditions as well as cancer development. More recently, MIF has been identified as an important pro-atherogenic factor. Its blockade could even aid plaque regression in advanced atherosclerosis. Promotion of atherogenic leukocyte recruitment processes has been recognised as a major underlying mechanism of MIF in vascular pathology. However, MIF's role in vascular biology is not limited to immune cell recruitment as recent evidence also points to a role for this mediator in neo-angiogenesis / vasculogenesis by endothelial cell activation and endothelial progenitor cell recruitment. On the basis of introducing MIF's chemokine-like functions, the current article focusses on MIF's role in vascular biology and pathology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23329140     DOI: 10.1160/TH12-11-0831

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  42 in total

Review 1.  Future research directions to improve fistula maturation and reduce access failure.

Authors:  Haidi Hu; Sandeep Patel; Jesse J Hanisch; Jeans M Santana; Takuya Hashimoto; Hualong Bai; Tambudzai Kudze; Trenton R Foster; Jianming Guo; Bogdan Yatsula; Janice Tsui; Alan Dardik
Journal:  Semin Vasc Surg       Date:  2016-08-26       Impact factor: 1.000

2.  Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases.

Authors:  Leandro Marcelo Martinez; Valeria Beatriz Fernández Vallone; Vivian Labovsky; Hosoon Choi; Erica Leonor Hofer; Leonardo Feldman; Raúl Horacio Bordenave; Emilio Batagelj; Federico Dimase; Ana Rodriguez Villafañe; Norma Alejandra Chasseing
Journal:  Clin Exp Metastasis       Date:  2013-10-31       Impact factor: 5.150

3.  The expression of microRNA-451 in human endometriotic lesions is inversely related to that of macrophage migration inhibitory factor (MIF) and regulates MIF expression and modulation of epithelial cell survival.

Authors:  Amanda Graham; Tommaso Falcone; Warren B Nothnick
Journal:  Hum Reprod       Date:  2015-01-29       Impact factor: 6.918

4.  Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis.

Authors:  Daniel Heinrichs; Marie-Luise Berres; Melanie Coeuru; Meike Knauel; Andreas Nellen; Petra Fischer; Claudia Philippeit; Richard Bucala; Christian Trautwein; Hermann E Wasmuth; Jürgen Bernhagen
Journal:  FASEB J       Date:  2014-08-13       Impact factor: 5.191

Review 5.  Vascular precursor cells in tissue injury repair.

Authors:  Xin Shi; Weihong Zhang; Liya Yin; William M Chilian; Jessica Krieger; Ping Zhang
Journal:  Transl Res       Date:  2017-02-21       Impact factor: 7.012

6.  Exendin-4 ameliorates oxidized-LDL-induced inhibition of macrophage migration in vitro via the NF-κB pathway.

Authors:  Ge-fei Ma; Song Chen; Lei Yin; Xiang-dong Gao; Wen-bing Yao
Journal:  Acta Pharmacol Sin       Date:  2013-12-16       Impact factor: 6.150

7.  Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor.

Authors:  Vinay Trivedi-Parmar; Michael J Robertson; José A Cisneros; Stefan G Krimmer; William L Jorgensen
Journal:  ChemMedChem       Date:  2018-04-23       Impact factor: 3.466

8.  Adding a Hydrogen Bond May Not Help: Naphthyridinone vs Quinoline Inhibitors of Macrophage Migration Inhibitory Factor.

Authors:  Thomas K Dawson; Pawel Dziedzic; Michael J Robertson; José A Cisneros; Stefan G Krimmer; Ana S Newton; Julian Tirado-Rives; William L Jorgensen
Journal:  ACS Med Chem Lett       Date:  2017-11-14       Impact factor: 4.345

9.  Novel Association of miR-451 with the Incidence of TEVG Stenosis in a Murine Model.

Authors:  Narutoshi Hibino; Cameron A Best; Alyson Engle; Svetlana Ghimbovschi; Susan Knoblach; Dilip S Nath; Nobuyuki Ishibashi; Richard A Jonas
Journal:  Tissue Eng Part A       Date:  2015-12-17       Impact factor: 3.845

10.  Compartmentalized protective and detrimental effects of endogenous macrophage migration-inhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia/reperfusion.

Authors:  Elisa A Liehn; Isabella Kanzler; Simone Konschalla; Andreas Kroh; Sakine Simsekyilmaz; Tolga Taha Sönmez; Richard Bucala; Jürgen Bernhagen; Christian Weber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-07-18       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.